Several articles have appeared over the last years devoted to mental side e
ffects during zonisamide (ZNS) treatment. In this study, we were particular
ly interested in psychotic episodes. Seventy-four epileptic patients with a
history of ZNS treatment were surveyed retrospectively over the period spa
nning 1 March 1984 to 30 June 1994. They were divided into two groups accor
ding to the presence or absence of psychotic episodes during ZNS treatment.
We analysed various factors pertaining to psychotic episodes during ZNS tr
eatment. Of the 74 patients 14 had psychotic episodes. We found that the in
cidence of psychotic episodes during ZNS treatment was several times higher
than the previously reported prevalence of epileptic psychosis, and that t
he risk of psychotic episodes was higher in young patients. In 13 patients,
psychotic episodes occurred within a few years of commencement of ZNS. In
children, obsessive-compulsive symptoms appeared to be related to psychotic
episodes. It is important to terminate ZNS as soon as possible if psychoti
c episodes develop and never restart, even if seizures become worse. It can
not definitely be proved that ZNS causes psychotic episodes, as information
on mental side effects during ZNS monotherapy is scant, but it does appear
likely that ZNS contributes to psychotic episodes during polytherapy. (C)
2000 BEA Trading Ltd.